Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: The impact of sarcopenia on clinical outcomes in men with metastatic castrate-resistant prostate cancer

  • Efthymios Papadopoulos,
  • Andy Kin On Wong,
  • Sharon Hiu Ching Law,
  • Lindsey Ze Jing Zhang,
  • Henriette Breunis,
  • Urban Emmenegger,
  • Shabbir M. H. Alibhai

The mean gait speed listed in Table 1 is incorrect. Participants with sarcopenia had a mean gait speed of 0.6m/s (SD: 0.1), whereas the mean gait speed of participants with no sarcopenia was 1.0m/s (SD: 0.2). Please see the correct Table 1 here.

thumbnail
Download:
Table 1. Baseline characteristics of study participants.

https://doi.org/10.1371/journal.pone.0314372.t001

Reference

  1. 1. Papadopoulos E, Wong AKO, Law SHC, Zhang LZJ, Breunis H, Emmenegger U, et al. (2023) The impact of sarcopenia on clinical outcomes in men with metastatic castrate-resistant prostate cancer. PLOS ONE 18(6): e0286381. https://doi.org/10.1371/journal.pone.0286381 pmid:37262068

Citation: Papadopoulos E, Wong AKO, Law SHC, Zhang LZJ, Breunis H, Emmenegger U, et al. (2024) Correction: The impact of sarcopenia on clinical outcomes in men with metastatic castrate-resistant prostate cancer. PLoS ONE 19(11): e0314372. https://doi.org/10.1371/journal.pone.0314372

Published: November 19, 2024

Copyright: © 2024 Papadopoulos et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.